SCHEMBL6988331

SCHEMBL6988331

CC1OCC(=O)C1(C)NC(=O)C(CNC(=O)c1ccc(-n2cccn2)cc1)c1cccc(O)c1

nearest known ligand 0.38

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 7/20 0.38
GCGR P47871 2/20 0.37
ELOVL6 Q9H5J4 1/20 0.35
KLKB1 P03952 3/20 0.34
ADAM17 P78536 1/20 0.34
PDE2A O00408 1/20 0.34
DGAT1 O75907 2/20 0.33
CHRM1 P11229 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985501 0.92 GCGR (0.41) KDM1AGCGRELOVL6ADAM17PDE2A
SCHEMBL6985507 0.86 SMN1; SMN2 (0.37)
SCHEMBL6988090 0.86 TP53 (0.35)
SCHEMBL6987228 0.85 CTSK (0.37)
SCHEMBL6749628 0.85 KDM1A (0.38) KDM1A
SCHEMBL6990344 0.84 MEN1 (0.37) PDE2A
SCHEMBL6986649 0.84 HTR1A (0.40)
SCHEMBL6991034 0.83 TAS1R3 (0.34)
SCHEMBL6989479 0.82 ATM (0.39) ADAM17PDE2A
SCHEMBL6990359 0.82 HPGD (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362042-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-19 EP disclosed
WO-2002057249-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed